Proteon Therapeutics, Inc.
(NASDAQ : PRTO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
-0.17%46.298.1%$690.94m
AMGNAmgen Inc.
0.65%178.621.3%$500.34m
CELGCelgene Corporation
-0.24%91.311.3%$433.36m
GILDGilead Sciences, Inc.
0.31%67.150.9%$403.27m
BIIBBiogen Inc.
-0.57%230.241.3%$373.38m
ILMNIllumina, Inc.
0.44%303.623.5%$355.71m
REGNRegeneron Pharmaceuticals, Inc.
0.26%299.152.6%$268.07m
ALXNAlexion Pharmaceuticals, Inc.
0.46%123.382.0%$197.90m
SRPTSarepta Therapeutics, Inc.
0.55%154.1014.7%$197.38m
VRTXVertex Pharmaceuticals Incorporated
0.68%177.351.9%$181.93m
AAgilent Technologies, Inc.
0.14%70.051.6%$141.02m
EXASExact Sciences Corporation
0.70%115.7524.1%$137.26m
INCYIncyte Corporation
-0.28%79.662.5%$109.56m
BLUEBluebird Bio, Inc.
2.06%136.4114.3%$95.74m
BMRNBioMarin Pharmaceutical Inc.
-0.99%81.564.3%$83.49m

Company Profile

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.